UNSPSC 51283404: Carfecillin

This classification denotes a urinary anti-infective agent and penicillin with the molecular formula C23H22N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9UU4XDB74X, chemically known as 6-((1,3-dioxo-3-phenoxy-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid (2s-(2alpha,5alpha,6beta))- but generally known as carfecillin, which bears US NIH Compound Identifier 33672. Carfecillin most often comes in base, phenyl, phenyl sodium, and sodium forms.

UNSPSC 51283404 Carfecillin is a Commodity-level code for a specific antibiotic pharmaceutical product; however, recent state and local opportunities tagged under this code do not reflect direct procurement of carfecillin itself. Instead, the code appears in piggyback and cooperative purchasing awards for broader pharmaceutical inventory — including antibiotics and emergency-response medications sourced through established vendor contracts and consortia. State and local health departments, counties, and community health systems use mechanisms like MMCAP Infuse and competitive IFB processes to procure pharmaceutical supplies in bulk, often bundling multiple drug products into single solicitations rather than acquiring individual active pharmaceutical ingredients or formulations separately. The issuing bodies include state health departments and county public health authorities, which typically consolidate demand across health facilities and emergency services to achieve volume discounts and streamlined distribution.

Recent activity centers on Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (notice 26482DPHPREPDB53392, closed award) for pharmaceutical warehouse supply including multiple tablet formulations with 12-month initial terms and renewal options through year three. Seminole County, Florida released an IFB (60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county community health building and potential FEMA funding. The carfecillin code shows limited direct procurement signals; recent opportunities under this taxonomy focus on established pharmaceutical supply contracts through cooperative purchasing vehicles rather than single-product solicitations.